This controlled trial randomly assigned patients with breast and prostate cancer undergoing treatment to complete one of three PRO measures : European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 ( QLQ-C30 ) , Supportive Care Needs Survey-Short Form ( SCNS-SF34 ) , or six domains from the Patient-Reported Outcomes Measurement Information System ( PROMIS ) .